✉news BusinessLabor first seen 9 h ago, last 9 h ago, peak #20

Novartis signs $7.8 billion mRNA deal with China's Abogen

Original: Novartis strikes about $7.8 billion mRNA deal with China's Abogen

Swiss drugmaker Novartis has agreed a deal worth about $7.8 billion with China's Abogen Biosciences, according to Reuters. The agreement centres on mRNA technology, marking a significant move by Novartis into the field and a landmark licensing arrangement for a Chinese biotech firm with a major Western pharmaceutical partner.

Why now: It is a large cross-border pharmaceutical deal linking a Swiss major with a Chinese mRNA biotech, a technology of intense industry interest.

NovartisAbogen Biosciences

Open on news →

Evidence

• Novartis strikes about $7.8 billion mRNA deal with China's Abogen · Reuters

API: https://socialmediatrends-api.osmike.com/v1/trends/713681